(NASDAQ: COYA) Coya Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 26.44%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.98%.
Coya Therapeutics's earnings in 2025 is -$20,338,928.On average, 9 Wall Street analysts forecast COYA's earnings for 2025 to be -$26,004,156, with the lowest COYA earnings forecast at -$29,994,760, and the highest COYA earnings forecast at -$21,600,442. On average, 9 Wall Street analysts forecast COYA's earnings for 2026 to be -$31,998,425, with the lowest COYA earnings forecast at -$35,731,463, and the highest COYA earnings forecast at -$27,395,683.
In 2027, COYA is forecast to generate -$27,011,006 in earnings, with the lowest earnings forecast at -$36,878,804 and the highest earnings forecast at -$11,414,868.